Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Age-related hemodynamic and morphologic differences in patients undergoing alcohol septal ablation for hypertrophic obstructive cardiomyopathy

Veselka J., Duchonová R., Pálenícková J., Zemánek D., Sváb P., Hájek P., Maly M., Blásko P., Tesar D., Cervinka P.

. 2006 ; 70 (7) : 880-884.

Language English Country Japan

Document type Comparative Study

BACKGROUND: Alcohol septal ablation (ASA) decreases the left ventricular (LV) outflow gradient and relieves symptoms in patients with highly symptomatic hypertrophic obstructive cardiomyopathy (HOCM). The aim of this study was to evaluate the early course of hemodynamic, morphologic and clinical changes in younger and elderly patients. METHODS AND RESULTS: Forty-four consecutive patients (age, 24-81 years) underwent the ASA procedure for HOCM. Clinical and echocardiographic data were obtained at baseline and periodically up to 12 months after ASA. There was a significant correlation between septum thickness and age at baseline and in the early post procedural period (p = 0.004 at baseline, p = 0.0033 days postoperative, p = 0.0193 weeks pos operative). The dependence of septal thickness on the duration of follow-up (p < 0.001) was significantly influenced by age (p = 0.026), which retained statistical significance after multivariate adjustment (p = 0.031). A decrease in the gradient of the LV outflow was identified in all age-related groups of patients (p < 0.001). After multivariate adjustment, there was a significant influence of age (p = 0.003) and creatine kinase-MB peak (p = 0.016) on the course of outflow gradient reduction. CONCLUSIONS: ASA is an effective treatment option for patients with HOCM, irrespective of their age. Younger patients are characterized by a thicker basal septum at baseline and a slower hemodynamic improvement within the early post procedural period.

000      
00000naa 2200000 a 4500
001      
bmc07522417
003      
CZ-PrNML
005      
20130602185208.0
008      
090430s2006 ja e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ja
100    1_
$a Veselka, Josef, $d 1965- $7 pna2005261820
245    10
$a Age-related hemodynamic and morphologic differences in patients undergoing alcohol septal ablation for hypertrophic obstructive cardiomyopathy / $c Veselka J., Duchonová R., Pálenícková J., Zemánek D., Sváb P., Hájek P., Maly M., Blásko P., Tesar D., Cervinka P.
314    __
$a Department of Cardiology, University Hospital Motol, Prague, Czech Republic. veselka.josef@seznam.cz
520    9_
$a BACKGROUND: Alcohol septal ablation (ASA) decreases the left ventricular (LV) outflow gradient and relieves symptoms in patients with highly symptomatic hypertrophic obstructive cardiomyopathy (HOCM). The aim of this study was to evaluate the early course of hemodynamic, morphologic and clinical changes in younger and elderly patients. METHODS AND RESULTS: Forty-four consecutive patients (age, 24-81 years) underwent the ASA procedure for HOCM. Clinical and echocardiographic data were obtained at baseline and periodically up to 12 months after ASA. There was a significant correlation between septum thickness and age at baseline and in the early post procedural period (p = 0.004 at baseline, p = 0.0033 days postoperative, p = 0.0193 weeks pos operative). The dependence of septal thickness on the duration of follow-up (p < 0.001) was significantly influenced by age (p = 0.026), which retained statistical significance after multivariate adjustment (p = 0.031). A decrease in the gradient of the LV outflow was identified in all age-related groups of patients (p < 0.001). After multivariate adjustment, there was a significant influence of age (p = 0.003) and creatine kinase-MB peak (p = 0.016) on the course of outflow gradient reduction. CONCLUSIONS: ASA is an effective treatment option for patients with HOCM, irrespective of their age. Younger patients are characterized by a thicker basal septum at baseline and a slower hemodynamic improvement within the early post procedural period.
650    _2
$a dospělí $7 D000328
650    _2
$a věkové faktory $7 D000367
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a hypertrofická kardiomyopatie $x patofyziologie $x patologie $x terapie $7 D002312
650    _2
$a katetrizační ablace $7 D017115
650    _2
$a látky tlumící činnost CNS $x aplikace a dávkování $7 D002492
650    _2
$a ethanol $x aplikace a dávkování $7 D000431
650    _2
$a srdeční septum $x patofyziologie $x patologie $7 D006346
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a výsledek terapie $7 D016896
650    _2
$a funkce levé komory srdeční $x účinky léků $7 D016277
655    _2
$a srovnávací studie $7 D003160
700    1_
$a Duchoňová, Radka $7 xx0080433
700    1_
$a Páleníčková, Jana $7 xx0089355
700    1_
$a Zemánek, David, $d 1972- $7 xx0079099
700    1_
$a Šváb, Přemysl, $d 1965- $7 xx0095369
700    1_
$a Hájek, Petr $7 xx0071248
700    1_
$a Malý, Martin, $d 1966- $7 mzk2004241073
700    1_
$a Blaško, Peter $7 xx0112679
700    1_
$a Tesař, David $7 xx0081874
700    1_
$a Červinka, Pavel, $7 xx0139185 $d 1964-
773    0_
$w MED00007056 $t Circulation journal $g Roč. 70, č. 7 (2006), s. 880-884 $x 1346-9843
910    __
$a ABA008 $b x $y 9
990    __
$a 20090310084605 $b ABA008
991    __
$a 20130602185552 $b ABA008
999    __
$a ok $b bmc $g 648856 $s 501854
BAS    __
$a 3
BMC    __
$a 2006 $b 70 $c 7 $d 880-884 $i 1346-9843 $m Circulation journal $x MED00007056
LZP    __
$a 2009-B3/ipme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...